Malaria therapeutics: are we close enough?
Open Access
- 14 April 2023
- journal article
- review article
- Published by Springer Nature in Parasites & Vectors
- Vol. 16 (1) , 1-26
Abstract
Malaria is a vector-borne parasitic disease caused by the apicomplexan protozoan parasite Plasmodium. Malaria is a significant health problem and the leading cause of socioeconomic losses in developing countries. WHO approved several antimalarials in the last 2 decades, but the growing resistance against the available drugs has worsened the scenario. Drug resistance and diversity among Plasmodium strains hinder the path of eradicating malaria leading to the use of new technologies and strategies to develop effective vaccines and drugs. A timely and accurate diagnosis is crucial for any disease, including malaria. The available diagnostic methods for malaria include microscopy, RDT, PCR, and non-invasive diagnosis. Recently, there have been several developments in detecting malaria, with improvements leading to achieving an accurate, quick, cost-effective, and non-invasive diagnostic tool for malaria. Several vaccine candidates with new methods and antigens are under investigation and moving forward to be considered for clinical trials. This article concisely reviews basic malaria biology, the parasite's life cycle, approved drugs, vaccine candidates, and available diagnostic approaches. It emphasizes new avenues of therapeutics for malaria. Graphical AbstractKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (IF190844)
- University Grants Commission (201610039436)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR24504/NER/95/746/2017)
- Indian Council of Medical Research (ISRM/11(35)/2019)
This publication has 226 references indexed in Scilit:
- Development of a Highly Sensitive Genus-Specific Quantitative Reverse Transcriptase Real-Time PCR Assay for Detection and Quantitation of Plasmodium by Amplifying RNA and DNA of the 18S rRNA GenesJournal of Clinical Microbiology, 2011
- Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potentialAsian Pacific Journal of Tropical Biomedicine, 2011
- Phosphatidylinositol 3-Phosphate, an Essential Lipid in Plasmodium, Localizes to the Food Vacuole Membrane and the ApicoplastEukaryotic Cell, 2010
- Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparumJournal of Medicinal Chemistry, 2009
- Functional Analysis of Protein Kinase CK2 of the Human Malaria Parasite Plasmodium falciparumEukaryotic Cell, 2009
- Changes in the Plasmodial Surface Anion Channel Reduce Leupeptin Uptake and Can Confer Drug Resistance in Plasmodium falciparum -Infected ErythrocytesAntimicrobial Agents and Chemotherapy, 2008
- Evidence for a Common Role for the Serine-Type Plasmodium falciparum Serine Repeat Antigen Proteases: Implications for Vaccine and Drug DesignInfection and Immunity, 2007
- Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial MechanismAntimicrobial Agents and Chemotherapy, 2007
- Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activityProceedings of the National Academy of Sciences, 2006
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003